SEP 20, 2026 · JOURNAL ARTICLE
From Proteomic Signatures to Candidate Endotypes in Obesity, Type 2 Diabetes, MASLD/MASH, and MetALD: Study Designs, Bioinformatics, and Biostatistical Strategies
Proteomes
Obesity, type 2 diabetes (T2D), metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), and dual-etiology metabol